NL8302947A - Benzamidederivaten. - Google Patents

Benzamidederivaten. Download PDF

Info

Publication number
NL8302947A
NL8302947A NL8302947A NL8302947A NL8302947A NL 8302947 A NL8302947 A NL 8302947A NL 8302947 A NL8302947 A NL 8302947A NL 8302947 A NL8302947 A NL 8302947A NL 8302947 A NL8302947 A NL 8302947A
Authority
NL
Netherlands
Prior art keywords
benzamide
imidazol
ylpropyl
group
general formula
Prior art date
Application number
NL8302947A
Other languages
English (en)
Dutch (nl)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of NL8302947A publication Critical patent/NL8302947A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8302947A 1982-08-24 1983-08-23 Benzamidederivaten. NL8302947A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24
GB8224296 1982-08-24

Publications (1)

Publication Number Publication Date
NL8302947A true NL8302947A (nl) 1984-03-16

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8302947A NL8302947A (nl) 1982-08-24 1983-08-23 Benzamidederivaten.

Country Status (23)

Country Link
US (1) US4507315A (sv)
JP (1) JPS5955873A (sv)
KR (1) KR840005717A (sv)
AT (1) ATA301083A (sv)
AU (1) AU1818083A (sv)
BE (1) BE897580A (sv)
CA (1) CA1195993A (sv)
CS (1) CS240973B2 (sv)
DE (1) DE3330403A1 (sv)
DK (1) DK386783A (sv)
ES (2) ES8502691A1 (sv)
FI (1) FI832989A (sv)
FR (1) FR2532310B1 (sv)
GB (1) GB2126225B (sv)
GR (1) GR78673B (sv)
IL (1) IL69544A0 (sv)
IT (1) IT1169775B (sv)
LU (1) LU84974A1 (sv)
NL (1) NL8302947A (sv)
NO (1) NO833024L (sv)
PT (1) PT77219B (sv)
SE (1) SE8304545L (sv)
ZA (1) ZA836191B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
AU5912800A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AU2005289887A1 (en) 2004-09-24 2006-04-06 Janssen Pharmaceutica, N.V. Sulfonamide compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
ZA836191B (en) 1984-04-25
GB2126225B (en) 1985-10-09
FI832989A (fi) 1984-02-25
SE8304545D0 (sv) 1983-08-22
IT8322629A0 (it) 1983-08-24
PT77219A (fr) 1983-09-01
GB8322539D0 (en) 1983-09-21
GR78673B (sv) 1984-09-27
CA1195993A (en) 1985-10-29
US4507315A (en) 1985-03-26
DK386783A (da) 1984-02-25
BE897580A (fr) 1984-02-23
FR2532310B1 (fr) 1986-01-10
FI832989A0 (fi) 1983-08-22
DE3330403A1 (de) 1984-03-01
IL69544A0 (en) 1983-11-30
DK386783D0 (da) 1983-08-23
AU1818083A (en) 1984-03-01
JPS5955873A (ja) 1984-03-31
ES8505935A1 (es) 1985-06-16
IT1169775B (it) 1987-06-03
CS240973B2 (en) 1986-03-13
GB2126225A (en) 1984-03-21
ATA301083A (de) 1985-11-15
SE8304545L (sv) 1984-02-25
NO833024L (no) 1984-02-24
ES525099A0 (es) 1985-01-16
FR2532310A1 (fr) 1984-03-02
PT77219B (fr) 1986-02-04
ES8502691A1 (es) 1985-01-16
ES528012A0 (es) 1985-06-16
LU84974A1 (fr) 1984-03-23
KR840005717A (ko) 1984-11-16
CS612483A2 (en) 1985-06-13

Similar Documents

Publication Publication Date Title
EP0353557B1 (de) Tetrahydro-1-benz-[c,d]-indol-propionsäure-sulfonamide
DK163268B (da) Fremgangsmaade til fremstilling af et 3-isothiazolonholdigt middel, biocidt eller biostatisk middel indeholdende 3-isothiazolon samt anvendelse af det biocide eller biostatiske middel til fremstilling af et kosmetisk eller farmaceutisk praeparat
Heimer et al. Organic disulfides and related substances. XXIX. Sulfenamides
NL8302947A (nl) Benzamidederivaten.
CN114031518B (zh) 一种苄胺或苄醇衍生物及其用途
Harvill et al. Haloalkyltetrazole and aminoalkyltetrazole derivatives
KR840002441B1 (ko) 과니딘의 헤테로사이클 유도체의 제조방법
BE897952A (fr) Procede de production d'imidazoles et intermediaires utilises a cet effet
EP0668857A1 (en) Process for the preparation of triazolone compounds
US4766241A (en) 2-Aminomethyl-6-sulfamoylphenol derivatives with salidiuretic activities
AU623015B2 (en) Preparation of n-(3(((2,6-dihalophenyl)amino)sulfonyl)-1h-1, 2,4--triazol-5-yl)amines
US3919277A (en) Mercaptoethylation of amines
EP1144408A1 (fr) N-(piperidin-4-yl)-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique
EP0371342B1 (de) 2-Halogensubstituierte N-Indolylethyl-sulfonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
WO1991018892A1 (fr) Derives de benzothiazole, leur preparation et les medicaments les contenant
IL24192A (en) 1-phenylsulfonyl-2-benzimidazolinones and 1-phenylsulfonyl-2-benzimidazolinethiones and process for their preparation
PL153449B1 (en) Procedure for the production of mercaptoacyloproline
KR840002440B1 (ko) 과니딘의 해태로 싸이클 유도체의 제조방법
KR100310936B1 (ko) Ｎ-(4-메틸벤젠술포닐)-ｎ'-(3-아자바이시클로[3,3,0]옥탄)우레아의 제조방법
NO790409L (no) Fremgangsmaate til fremstilling av nye foretrete hydroksybenzodiheterocykler
KR840002439B1 (ko) 과니딘의 헤테로 싸이클 유도체의 제조방법
FI86172C (sv) Nya nitraminodiarylsulfoxidderivat
JPS6144886A (ja) Ｎ−（２′−テトラヒドロフラニル）アルキル安息香酸アミド及びその製造方法
EP0013786A1 (en) Imidazole derivatives, pharmaceutical compositions containing them and their preparation
EP1438301A1 (en) Process of production of n-alkyl-2-benzthiazolylsulfeneimides, device for their production and method of their purification

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed